[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1356062T3 - Frembringelse af rekombinanter af kunstigt gærkromosom af human cytomegalovirus - Google Patents

Frembringelse af rekombinanter af kunstigt gærkromosom af human cytomegalovirus

Info

Publication number
DK1356062T3
DK1356062T3 DK01994211T DK01994211T DK1356062T3 DK 1356062 T3 DK1356062 T3 DK 1356062T3 DK 01994211 T DK01994211 T DK 01994211T DK 01994211 T DK01994211 T DK 01994211T DK 1356062 T3 DK1356062 T3 DK 1356062T3
Authority
DK
Denmark
Prior art keywords
recombinants
generation
human cytomegalovirus
yeast chromosome
artificial yeast
Prior art date
Application number
DK01994211T
Other languages
English (en)
Inventor
Huang Huang
Peter Ghazal
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of DK1356062T3 publication Critical patent/DK1356062T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/206—Pseudochromosomes, minichrosomosomes of yeast origin, e.g. YAC, 2u
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/10—Vectors comprising a non-peptidic targeting moiety

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01994211T 2000-11-03 2001-10-30 Frembringelse af rekombinanter af kunstigt gærkromosom af human cytomegalovirus DK1356062T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/705,400 US6692954B1 (en) 2000-11-03 2000-11-03 Generation of human cytomegalovirus yeast artificial chromosome recombinants

Publications (1)

Publication Number Publication Date
DK1356062T3 true DK1356062T3 (da) 2006-05-15

Family

ID=24833288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01994211T DK1356062T3 (da) 2000-11-03 2001-10-30 Frembringelse af rekombinanter af kunstigt gærkromosom af human cytomegalovirus

Country Status (9)

Country Link
US (1) US6692954B1 (da)
EP (1) EP1356062B1 (da)
AT (1) ATE317016T1 (da)
AU (1) AU2002246634A1 (da)
DE (1) DE60117053T2 (da)
DK (1) DK1356062T3 (da)
ES (1) ES2255583T3 (da)
HK (1) HK1055762A1 (da)
WO (1) WO2002057437A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790867B2 (en) * 2002-12-05 2010-09-07 Rosetta Genomics Inc. Vaccinia virus-related nucleic acids and microRNA
WO2005052159A1 (en) 2003-11-28 2005-06-09 The University Of Sydney Latent phase viral interleukin-10-(vii-10) and uses thereof
US8088902B2 (en) * 2004-04-05 2012-01-03 The Rockefeller University DNA virus microRNA and methods for inhibiting same
CN101389214A (zh) 2004-10-22 2009-03-18 雷维维科公司 具有基因修饰免疫系统的有蹄类动物
US9267132B2 (en) 2007-10-08 2016-02-23 Synthetic Genomics, Inc. Methods for cloning and manipulating genomes
DK2348827T3 (da) 2008-10-27 2015-07-20 Revivicor Inc Immunkompromitterede hovdyr
SG10201400436PA (en) 2009-03-06 2014-06-27 Synthetic Genomics Inc Methods For Cloning And Manipulating Genomes
JP2013520989A (ja) 2010-03-05 2013-06-10 シンセティック ジェノミクス インコーポレーテッド ゲノムのクローニングおよび操作のための方法
WO2014036404A2 (en) 2012-08-31 2014-03-06 Synthetic Genomics, Inc. Crowding agent-induced nucleic acid transfer into a recipient host cell
AU2013355368A1 (en) * 2012-12-04 2015-05-28 Merck Sharp & Dohme Corp. Conditional replicating viral vectors
EP3888675A1 (en) * 2013-09-24 2021-10-06 Duke University Compositions, methods and kits for eliciting an immune response
WO2016168741A2 (en) * 2015-04-16 2016-10-20 Spencer Juliet V Detection of human cytomegalovirus
WO2018005559A1 (en) 2016-06-27 2018-01-04 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959466A (en) 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof
US5552143A (en) 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US5591439A (en) 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
WO1995003400A1 (en) 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
US5721354A (en) 1995-03-31 1998-02-24 Aviron Human cytomegalovirus DNA sequences
DE19733364A1 (de) 1997-08-01 1999-02-04 Koszinowski Ulrich H Prof Verfahren zur Klonierung eines großen Virusgenoms
US6277621B1 (en) 1998-02-26 2001-08-21 Medigene, Inc. Artificial chromosome constructs containing foreign nucleic acid sequences

Also Published As

Publication number Publication date
EP1356062B1 (en) 2006-02-01
DE60117053D1 (de) 2006-04-13
ES2255583T3 (es) 2006-07-01
WO2002057437A2 (en) 2002-07-25
AU2002246634A1 (en) 2002-07-30
DE60117053T2 (de) 2006-08-17
WO2002057437A3 (en) 2003-08-14
HK1055762A1 (en) 2004-01-21
US6692954B1 (en) 2004-02-17
ATE317016T1 (de) 2006-02-15
EP1356062A2 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
DK1356062T3 (da) Frembringelse af rekombinanter af kunstigt gærkromosom af human cytomegalovirus
WO2005014806A3 (en) Conserved hbv and hcv sequences useful for gene silencing
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
WO2005012545A3 (en) Cytomegalovirus gene function and methods for developing antivirals, anti-cmv vaccines, and cmv-based vectors
WO2000003030A3 (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
DK1159405T3 (da) Virale partikler, som frigives efter infektion med human cytomegalovirus, og deres anvendelse som vaccine
CY1106883T1 (el) Ανασυνδυασμενος ιος ευλογιας που περιεχει τουλαχιστον δυο υποκινητες ατι ιου ευλογιας αγελαδας.
PT1234024E (pt) Construcoes de cromossomas artificiais contendo sequencias de acido nucleico capazes de dirigir a formacao de um virus de rna recombinante
DK1176205T3 (da) Ekspression af alkalisk phosphatase i gær
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
MXPA03000061A (es) Manipulacion de virus de arn encadenados negativos mediante redisposicion de sus genes y usos de los mismos.
DE60238309D1 (de) Tomegalovirus genom mit konserviertem wildtyp-charakteristika klinisher isolate enthält
WO2006069064A3 (en) Conserved hbv and hcv sequences useful for gene silencing
AU2003255315A1 (en) Vaccinia virus host range genes to increase the titer of avipoxviruses
ATE412762T1 (de) Vektor zur integration von heterologen sequenzen in poxvirusgenomen
HK1076835A1 (en) Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
WO2004067032A3 (en) Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes
HUP0103871A2 (hu) Rekombináns CELO-vírus és CELO vírus DNS
ATE389726T1 (de) Infektiöse vektoren und pflanzenklone, die sich von turnip mosaikvirus herleiten
SE0002498D0 (sv) Papillomavirus vaccine
WO2001011065A3 (en) Hepatitis a virus clones adapted for growth in agmk cells
ATE359811T1 (de) Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe